Agranulocytosis and Haematocrit abnormal

Summary:

Haematocrit abnormal is reported only by a few people with Agranulocytosis.

The study analyzes which people have Haematocrit abnormal with Agranulocytosis. It is created by eHealthMe based on 4 people who have Haematocrit abnormal and Agranulocytosis from the Food and Drug Administration (FDA), and is updated regularly.

What is Agranulocytosis?

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection) is found to be associated with 2,327 drugs and 3,592 conditions by eHealthMe. Check the latest studies of Agranulocytosis.

What is Haematocrit abnormal?

Haematocrit abnormal is found to be associated with 280 drugs and 595 conditions by eHealthMe. Check the latest studies of Haematocrit abnormal.

On Jul, 20, 2026

4 people who have Agranulocytosis and Haematocrit Abnormal are studied.

Would you have Haematocrit abnormal when you have Agranulocytosis?

Gender of people who have Agranulocytosis and experienced Haematocrit Abnormal *:

female: 100 %
male: 0.0 %

Age of people who have Agranulocytosis and experienced Haematocrit Abnormal *:

Common co-existing conditions for these people *:

Sarcoma Uterus (type of tumour of uterus cancer): 1 person, 25.00%
Breast Cancer Female: 1 person, 25.00%

Common drugs taken by these people *:

Common symptoms for these people *:

Haemoglobin Abnormal: 3 people, 75.00%
Platelet Count Abnormal: 2 people, 50.00%
Fatigue (feeling of tiredness): 2 people, 50.00%
White Blood Cell Disorder: 1 person, 25.00%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 25.00%
Hypokalemia (low potassium): 1 person, 25.00%
Hypoglycemia (low blood sugar): 1 person, 25.00%
Gravitational Oedema (abnormally large fluid volume in the circulatory system makes obese): 1 person, 25.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 25.00%
Essential Hypertension (primary hypertension): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Haematocrit abnormal?

- Check whether Haematocrit abnormal is associated with a drug or a condition

Related publications that referenced our studies

Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .
Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .

Related studies:

Treatments, associated drugs and conditions:

Agranulocytosis (213,267 reports)
Haematocrit abnormal (1,610 reports)

All the drugs that are associated with Haematocrit abnormal:

Haematocrit abnormal (280 drugs)

All the conditions that are associated with Haematocrit abnormal:

Haematocrit abnormal (595 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Haematocrit abnormal and Agranulocytosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.